Related by context. All words. (Click for frequent words.) 71 alpha antagonist 71 Locked Nucleic Acid 69 CYT# potent vascular disrupting 69 acetonide FA 69 liposomal formulation 69 PEGylated anti 69 IAP inhibitor 69 mertansine 68 Genasense ® oblimersen 68 developing Bicifadine serotonin 68 nasal calcitonin product 68 LymphoStat B TM 68 pipeline ImmunoGen collaborators 68 Oracea TM 68 vapreotide acetate 68 IMiDs 68 ALN HPN 68 Completes Patient Enrollment 68 LymphoStat B belimumab 68 HGS ETR1 mapatumumab 67 mRNA antagonists 67 proprietary polysaccharide 67 FOLOTYN ® 67 rxRNA 67 Mg Usa 67 CD# CEA 67 P#X# antagonist 67 ADP receptor antagonist 67 including eniluracil ADH 67 HuMax 67 kidney urologic 67 vinorelbine tartrate 67 peptidic compound 67 sapacitabine CYC# 67 hormone LHRH antagonist 67 MAGE A3 ASCI 67 topical gel formulation 67 AAG geldanamycin analog 67 SAR# [002] 67 Zorbtive TM 66 PGL# 66 norepinephrine reuptake inhibitor 66 TRIOLEX HE# APOPTONE HE# 66 Azedra 66 product platforms AZX# 66 liver resection surgeries 66 investigational immunotherapy 66 Selective Electrochemical Tumor Ablation 66 ATRA IV 66 Initiates Enrollment 66 Tezampanel 66 Targeted Chemotherapy 66 XL# anticancer compounds 66 5 HT3 antagonist 66 TRACON Pharmaceuticals 66 Ganciclovir 66 telomerase therapeutic 66 successfully commercialize Iluvien 66 TNF Tumor Necrosis Factor 66 Locked Nucleic Acid LNA 66 gemcitabine cisplatin 66 Receives Orphan Drug Designation 66 granisetron formulated 66 Telik logo TELINTRA 66 thymidylate synthase TS 66 signal averaging electrocardiography 66 RECOTHROM R 66 AFREZZA TM 66 sodium Injection 66 IMiDs ® compound 66 Panzem R 66 Reports Preclinical Data 66 platinum chemotherapeutic 66 Exherin 66 small molecule glucokinase 66 directed radiotherapeutic antibody 66 metaglidasen 66 Novasome R 66 Vidaza R 66 IMiDs R 66 Provectus Pharmaceuticals specializes 66 Pruvel TM 66 HuMax TAC 66 Romiplostim 66 Initiates Phase II 65 docetaxel Taxotere ® 65 Therapeutic Competitors companiesandmarkets.com adEgemonye 65 urocortin 2 65 Sapacitabine 65 Gamunex C 65 Fludara ® 65 YONDELIS 65 TRANSDUR ® 65 Submits NDA 65 targeted radiotherapeutic 65 MKC# 65 EOquin TM 65 candidates Azedra 65 Piperacillin 65 sodium thiosulfate STS 65 5 lipoxygenase inhibitor 65 COLAZAL R 65 treat male hypogonadism 65 selective A2A adenosine receptor 65 ospemifene 65 PSMA ADC 65 treat refractory angina 65 GRNVAC1 65 PORxin TM platforms 65 Modrenal R 65 MKC# MT 65 Seliciclib 65 Presents Preclinical 65 Safinamide 65 Xcellerated T Cells 65 lead molecular radiotherapeutic 65 phase III isavuconazole 65 Testim R 65 subsidiaries visit http:/www.apricusbio.com 65 Soliris eculizumab 65 Hsp# Inhibitor 65 MSCRAMM ® 65 VitiGam 65 ALN PCS 65 APC Targeting Technology 65 R Saizen R 65 RNA antagonist 65 memantine HCl 65 polysaccharide polymer 65 Recombinant Human 65 small molecule thrombopoietin 65 candidate deforolimus 65 ENMD # 65 ChromoCure develops 65 TM Aganocide 65 apoptosis proteins 65 sodium glucose transporter 65 humanized therapeutic 65 DEB# 65 TRANSDUR ™ 65 intranasal delivery 65 hypervascular tumors 65 IMiDs ® 65 liposomal delivery 65 MCSP respectively 65 pralatrexate injection folate analogue 65 prostone 65 intravesical infusion therapy 65 Vitrasert R 65 Initiates Clinical 65 proprietary PEGylation 65 PERLANE 65 PrevOnco ™ 65 VISICOL R 65 Pruvel ™ 65 Liprotamase 65 THR beta agonist 65 protein tyrosine phosphatase 1B 65 Atripla combines 65 Archexin 64 candidate XP# 64 oral gallium 64 ZOLINZA 64 proprietary BiTE ® 64 Warfarin Coumadin 64 tiapamil 64 SinuNase TM 64 Altera Nebulizer System 64 oncolytic virus therapies 64 anticancer compound 64 Therapeutic Competitors Companies 64 Febuxostat 64 fusion enhancers 64 CCR9 antagonist 64 HuMax HepC 64 orally inhaled 64 5 HT6 64 Epiphany Biosciences 64 huC# DM4 64 2 methoxyestradiol 64 investigational humanized monoclonal antibody 64 Crofelemer budesonide foam 64 telomerase inhibitor drug 64 Announces Poster Presentations 64 symbol AVXL 64 MKC# MKC# PP 64 candidates Azedra TM 64 NYSE Amex YMI 64 receptor inhibiting monoclonal 64 KL4 Surfactant 64 Pancreas Cancer Vaccine 64 anionic backbone 64 RTP #i 64 BrachySil 64 somatostatin analogue 64 #D#C# 64 alpha folate receptor 64 accumulate preferentially 64 CTAP# Capsules 64 TRISENOX ® 64 NovaDel oral spray 64 Neuromodulation System 64 Inc. AMEX YMI 64 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 64 sarcoma melanoma 64 AEG# 64 erlotinib Tarceva R 64 compound KOS 64 Sym# 64 FUSILEV ® 64 PrevOnco 64 either acutely decompensated 64 motexafin gadolinium Injection 64 docetaxel Taxotere R 64 generation purine nucleoside 64 5 HT2A serotonin 64 transthyretin TTR 64 synthetic retinoid 64 Toctino ® alitretinoin 64 Evoltra ® 64 monoclonal antibody IgG1 Mab 64 Granulocyte Colony Stimulating Factor 64 MEK inhibitor 64 octreotide implant 64 Pertuzumab 64 Personalized Immunotherapy 64 Submits Response 64 Genasense R oblimersen 64 delivers fluocinolone acetonide FA 64 Pegloticase 64 urethral bulking agent 64 SPL# Gel vaginal microbicide 64 rusalatide acetate 64 Poly ICLC 64 cosmetic cosmeceutical products 64 Panzem R NCD 64 arsenic trioxide injection 64 Receives Approvable Letter 64 human IgG1 monoclonal 64 DUROS 64 personalized cellular immunotherapy 64 Customized Linker Technology 64 Combivir Kivexa 64 oral prodrug 64 Luveris R Ovidrel R 64 Wafer polifeprosan 64 auristatin E MMAE 64 ferumoxytol Injection 64 SinuNase ™ 64 Thrombin topical Recombinant 64 Orally administered 64 ATL# [002] 64 CD# expressing 64 novel synthetic peptide 64 Initiate Clinical Trial 64 inhibitor PPI 64 Presents Preclinical Data 64 Files IND 64 Novel Oral 64 next generation URAT1 64 Proellex TM 64 orally bioavailable mimics 64 oral dual endothelin 64 INxin TM 64 brand ciclesonide HFA 64 label Lipofen R 64 Resten NG 64 angiotensin analog 64 cromolyn sodium 64 targeted anticancer biopharmaceuticals 64 external counterpulsation systems 64 hyaluronidase enzyme 64 RECOTHROM ® 64 IRX 2 64 TOCOSOL Camptothecin 64 Investigational eFlow Nebulizer System 64 DURECT proprietary 64 Vidaza azacitidine 64 2A receptor agonist 64 investigational monoclonal antibody 64 octreotide acetate 64 acyclovir Lauriad R 64 Onalta 64 CEQ# 64 lintuzumab SGN 64 Alfacell proprietary ribonuclease 64 QuadraSphere 64 Peginterferon alfa 2b 64 proprietary MSCRAMM ® 64 novel DACH platinum 64 RANK Ligand inhibitor 64 epoetin delta 64 5 Fluorouracil 64 Intravenous Human 64 agonistic human 64 apoptosis inducer 64 Elotuzumab 64 trademarks Vitrasert R 64 TÎ ² 4 64 HepaMate 64 PHX# 64 BrachySil TM 64 Gentamicin Surgical Implant 64 NUVIGIL ® 64 Nasdaq HALO biopharmaceutical 64 Inc. Nasdaq IMGN 64 forodesine 64 CCX# 64 defensin mimetic antibiotic 64 Azacitidine 64 selective modulator 64 PROfusion 64 using VIAdel TM 64 PI3K/Akt pathway inhibitor 64 Prodarsan R 64 overactive bladder VANTAS R 64 GW# [003] 64 Iluvien ® 63 BRAF kinase 63 tests miRview TM 63 Vitamin D analogue 63 Ceflatonin R 63 targets Galectin receptors 63 inhaled formulation 63 NYSE Amex PBTH 63 reformulates existing FDA 63 targeted antifolate 63 Ceragenin ™ 63 GVAX ® 63 Rigel R# 63 novel synthetic PEGylated 63 Loceryl ® 63 NuMimetic TM 63 removes endotoxin 63 Janus Kinase 63 Mg Uk 63 R sorafenib tablets 63 ESBA# 63 PEG SN# 63 histone deacetylase HDAC 63 humanized interleukin 6 63 Drug Eluting Stent System 63 novel VDA molecule 63 c Raf kinase 63 Nanobody 63 Locteron ® 63 Amrubicin 63 Veregen TM 63 Regeneron Pharma 63 ImmunoGen TAP technology 63 injectable formulation 63 Fortical R 63 PDX pralatrexate 63 adenosine injection 63 NASDAQ BTRX pharmaceutical 63 topically applied SEPA 63 markets Testim ® 63 Symadex 63 OMNARIS Nasal Spray 63 raloxifene Evista 63 selective inhibition 63 Arikace 63 angiogenesis inhibitor 63 Inc. OTCBB ECTE 63 Tyrosine Kinase Inhibitor 63 chimeric monoclonal antibody 63 Clearant Process ® 63 Tesetaxel 63 TELINTRA R 63 Biomerix Corporation 63 OTCBB HXBM developer 63 Phase 1b clinical trials 63 system vaporizes unformulated 63 hPTH #-# 63 DiLA2 63 peptibody 63 Meets Primary Endpoint 63 lidocaine hydrochloride monohydrate powder 63 CD4 monoclonal antibody 63 Pivotal Phase III 63 Hexvix ® 63 E1 INT TM 63 FDA APPROVES 63 non nucleoside inhibitor 63 XmAb ™ 63 SIX RO ROG 63 BXT # 63 Vascular Closure Device 63 Aeolus Pharmaceuticals Announces 63 Vaccine Adjuvant 63 CORT # 63 Achieves Primary Endpoint 63 recurrent metastatic ovarian cancer 63 maximally tolerated dose 63 Xcytrin R 63 Angiotensin Converting Enzyme 63 taxane derivative 63 sodium glucose cotransporter 63 coronary stent merged 63 Nasdaq PARD 63 HepDirect prodrug 63 drug ISA# 63 INSPIRE Trial Phase III 63 PEGylated interferon 63 novel emulsion formulation 63 IONSYS TM 63 anti CD3 antibody 63 Captisol ® 63 intranasal formulation 63 Kuvan sapropterin dihydrochloride 63 Exelixis compounds 63 HuMax TF 63 Qutenza TM 63 markets HP Acthar 63 sorafenib tablets 63 humanized monoclonal 63 nucleotide analog 63 Genentech sanofi aventis 63 Zemiva TM 63 Budesonide foam crofelemer 63 delta opioid receptor 63 cetuximab Erbitux R 63 MOVIPREP R 63 delivery polymer matrix 63 vaccine GRNVAC1 63 Ecallantide 63 Janus kinase 63 Zenpep 63 monoclonal antibody conjugated 63 Locteron exclusively 63 Liposomal 63 GLP1 INT TM 63 potent topoisomerase II 63 Oracea R 63 Ophena 63 novel peptide 63 PRNewswire FirstCall YM BioSciences 63 Cetuximab Erbitux 63 lucinactant 63 Transdel TM 63 alpha#beta# integrin 63 Nasdaq XTLB 63 Degarelix 63 JAK1 63 GAMMAGARD 63 systemically administered 63 mTOR mammalian target 63 GED aPC 63 Aflibercept 63 subcutaneous formulation 63 mda 7 63 plasmid encoding 63 PEGylated Fab fragment 63 PDE4 inhibitor 63 VEGFR2 inhibitor 63 ZEVALIN ® 63 REPRONEX R menotropins 63 Glufosfamide 63 proprietary intranasal insulin 63 selective kinase inhibitor 63 By JAMAAL ABDUL 63 Marqibo TM 63 Nexavar sorafenib tablets 63 Vascugel 63 myelofibrosis polycythemia vera 63 hypoxia inducible factor 63 Retisert ® 63 RONDEL ™ 63 GLASSIA 63 visit http:/www.mannkindcorp.com 63 Initiates Phase III 63 liposome encapsulated 63 rHuPH# recombinant human 63 soft gelatin capsule 63 dermatology therapies 63 interferon gamma 1b 63 aurora kinase 63 VAPRISOL 63 trastuzumab DM1 T DM1 63 HuMax Wnt 63 carcinoma HCC 63 Nutra Pharma wholly owned 63 erlotinib Tarceva ® 63 Methylnaltrexone 63 MyVax R 63 fluocinolone acetonide 63 Cerashield 63 Sufentanil 63 Aganocide 63 inhibit oxidative stress 63 corticosteroid dexamethasone 63 mu opioid receptor antagonist 63 Aradigm Logo 63 Nasdaq ENZN 63 hormone agonist 63 demonstrated antitumor activity 63 Tumor Response 63 HepaGam B TM 63 LAB CGRP 63 LEUKINE 63 selective phosphodiesterase 63 Parathyroid Hormone 63 EGFR HER2 63 EXPAREL TM 63 highly selective inhibitor 63 ZFP TF 63 Besivance 63 Zirgan 63 Nasdaq IMGN 63 EHT AGN 63 Enzon Pharmaceuticals Inc 63 anticancer therapeutics 63 CCR5 mAb 63 Albuferon TM 63 Xolegel 63 TLR9 agonists 63 Naglazyme R 63 Nasdaq IMGN biotechnology 63 TAFA# 63 Arno Therapeutics 62 Emergent marketed 62 Optical Biopsy System 62 DepoDur 62 Onco TCS 62 Hedgehog Pathway Inhibitor 62 G#DT 62 riboflavin vitamin B2 62 tumor xenograft models 62 CyDex Pharmaceuticals Inc. 62 RhuDex ® 62 Locteron combines 62 Matrix Phase 2b 62 refractory chronic lymphocytic 62 OncoVEX 62 TPI ASM8 62 plasma kallikrein inhibitor 62 Targretin capsules 62 ProLindac TM 62 please visit http:/www.vandapharma.com 62 thalidomide Thalomid 62 oral immunomodulatory 62 HepaGam B 62 Quinamed 62 Zysolin TM 62 BHT DNA 62 Gleevec imatinib mesylate 62 JAK inhibitors 62 oral salmon calcitonin 62 Annamycin 62 BCR ABL inhibitors 62 GATTEX ® 62 Myolimus 62 compound PMX # 62 Serostim ® 62 Nasdaq MITI biopharmaceutical 62 please visit www.advaxis.com 62 thromboxane A2 62 vidofludimus 62 ruxolitinib 62 Cobalamin TM 62 XL# XL# XL# XL# 62 biologic DMARD 62 ImmuKnow R 62 IL# PE#QQR 62 reslizumab 62 YM AIM YMBA 62 Ovitrelle R Serostim 62 selective immunoproteasome inhibitor 62 Tibotec Therapeutics division 62 Cardium Therapeutics TM 62 Initiates Clinical Trial 62 Aztreonam 62 multi kinase inhibitor 62 Golimumab 62 paclitaxel Taxol ® 62 AKT inhibitor 62 Pazopanib 62 programs visit http:/www.bionovo.com 62 therapeutic monoclonal antibodies 62 Microwave Ablation System 62 chemically modified siRNA 62 bevacizumab Avastin R 62 Albugon 62 Emezine 62 oral Hsp# inhibitor 62 SUTENT ® 62 MAbs targeting 62 HepeX B TM 62 Protein Kinase C 62 apomorphine hydrochloride 62 evaluating tivozanib 62 AMEX RGN 62 cortisol synthesis 62 PNP inhibitor 62 index assay IVDMIA 62 leading oral taxane 62 receptor tyrosine kinase inhibitor 62 GEM OS2 62 REGN# 62 Exjade deferasirox 62 Vidaza ® 62 FGFR 62 Vaxfectin TM 62 antisense inhibitors 62 Levoleucovorin 62 PROSTASCINT R 62 PRN FDA Approves 62 JAK#/JAK# inhibitor CYT# 62 histone deacetylase inhibitor 62 Abbokinase 62 Lubiprostone 62 TRO# 62 therapeutically inactive prodrug 62 NUEDEXTA ™ 62 prostanoid 62 tubulin inhibitor 62 miconazole Lauriad R 62 Litx 62 acne impetigo 62 methylnaltrexone bromide 62 Begins Dosing 62 Ostarine ™ 62 uricase 62 ZARS Pharma 62 E2F Decoy 62 adecatumumab MT# 62 Civacir 62 OMP #M# 62 Xanafide 62 small molecule tyrosine 62 Nventa proprietary CoVal 62 OctoPlus licensed 62 Factor VIIa Factor VIII 62 doxercalciferol 62 Frova ® 62 Chemokine Receptor 62 GlycoPEGylated hemostasis compounds 62 small molecule Hedgehog 62 orally dosed 62 monoclonal antibody MAb 62 Epidermal Growth Factor Receptor 62 Announces FDA Clearance 62 technology PolyActive ® 62 Gene Expression RAGE 62 HCl Tablets 62 Interferon alpha 62 Luteinizing Hormone Releasing Hormone 62 transdermal spray 62 Myrexis Inc. 62 Myocet 62 immune modulatory 62 Vaprisol 62 Powerlink ® 62 ATL# [001] 62 MBRX 62 ALN TTR 62 Plicera 62 MTP inhibitor 62 RAS MAPK pathway 62 HuMax EGFr 62 Vicinium TM 62 topoisomerase II inhibitor 62 biodegradable implant 62 TLK# 62 Irinotecan 62 induced macular edema 62 Ophena TM 62 siRNAs targeting 62 drug zotarolimus 62 Nanobody R 62 r hGH 62 Sanvar R 62 Announces Tentative Approval 62 Pharmacokinetics PK 62 Phase III Pivotal 62 CRMD# 62 Pralatrexate 62 AtuPLEX 62 adenosine A2A 62 novel prodrug 62 Pyridorin 62 EDEMA3 62 BCG refractory carcinoma 62 Alocrest 62 HYVISC ® treatment 62 Oral NKTR 62 Biolimus A9 62 radiolabeled TM# 62 products MKC# PP 62 Orapred ODT 62 IgG1 monoclonal antibody 62 Dementia Related Psychosis 62 Vantas 62 ADCC enhanced 62 pan HDAC inhibitor 62 PARI Pharma GmbH 62 non porcine pancreatic 62 agonist compounds 62 Expression PACE 62 oral picoplatin 62 Talabostat 62 2 inhibitor CYT# 62 Spiegelmer ® 62 R lenalidomide 62 Penwest Pharmaceuticals Co 62 platform HDL Mimetic 62 BENLYSTA ® 62 volociximab 62 Serdolect ® 62 Tarmogen 62 cMET 62 IMPACS R 62 ALN HTT 62 cyclobenzaprine hydrochloride extended 62 Sudhir Agrawal D.Phil 62 Revimmune 62 REMINYL ® 62 Tumor Necrosis Factor 62 efaproxiral 62 Aviptadil 62 pharmacologically active isomer 62 enhanced skin permeation 62 Metabasis Therapeutics 62 Phase #b/#a clinical 62 MyVax ® 62 Files Investigational 62 investigational pharmacologically unique 62 Sanctura XR 62 Combination REOLYSIN R 62 Bezielle 62 nucleoside analog 62 trospium 62 candidate CRLX# 62 Inc. NASDAQ ZLCS 62 Bendamustine 62 collagen sponge seeded 62 AERx R 62 Veronate R 62 molecular imaging radiopharmaceutical 62 IG HCR ;) CO 62 ® bortezomib 62 treat chronic sinusitis 62 dasatinib Sprycel 62 Gel repository corticotropin injection 62 virus HCV protease inhibitor 62 Q#IR 62 R rilonacept Injection 62 Junovan TM 62 HP Acthar R 62 including Random Activation 62 Bioral 62 SNALP technology 62 Inc. OTCBB SPRX 62 TO AVOID PREGNANCY WHILE 62 Perifosine KRX 62 mSEPT9 biomarker 62 TKB# 62 COREG CR 62 TLR9 agonist 62 Zalypsis 62 VYVANSE TM lisdexamfetamine 62 SYCREST 62 potent suppressor 62 4SC AG ISIN DE# 62 HuCAL PLATINUM ® CysDisplay 62 researches develops licenses 62 tafamidis 62 Company proprietary Biochronomer 62 Factor Receptor 62 markets COLAZAL 62 Adnectin 62 Dacogen injection 62 Delivery System NTDDS 62 ocular formulation 62 Inc. NASDAQ VSGN 62 Sumatriptan Succinate 62 fluoropyrimidine 62 Navelbine ® 62 Elagolix 62 humanized antibody 62 vinca alkaloids 62 cyclin dependent kinase CDK 62 Tengion Neo Bladder Augment 62 alvespimycin 62 antibody MAb 62 Oxiplex 62 Cleviprex TM clevidipine 62 Fibrin MB 62 5 HT4 62 Septin9 biomarker 62 CIMZIA r 62 SPRIX ® 62 Humira adalimumab 62 Aptocine 62 L BLP# 62 Kahalalide F 62 adalimumab Humira 62 BioSilicon TM 62 Nasdaq DVAX 62 oncologic diseases 62 attach auristatin 62 Loramyc R 62 Insegia 62 hyperphenylalaninemia HPA due 61 BEMA ® 61 Vandetanib 61 developing ACAPODENE 61 topically administered 61 MGd 61 phase IIb trial 61 LensAR Laser System 61 metastatic neuroendocrine tumors 61 herpetic keratitis 61 Nerve Targeting Drug 61 Teysuno 61 NicVAX TM 61 visit www.dobimedical.com 61 secretory phospholipase A2 61 manufactures minimally invasive 61 ARRY # 61 Shows Statistically Significant 61 pentadentate logo R 61 Proquin XR 61 RELOVAIR ™ 61 Dapagliflozin 61 Opterone R 61 UltiMAb TM 61 molecular chaperone regulation 61 hyaluronidase rHuPH# 61 PATHFINDER R 61 receptor modulators 61 immatics 61 DURIN TM 61 VBLOC R 61 chronic eosinophilic leukemia 61 tumor activated prodrug 61 Kepivance 61 amifostine 61 Prodrug TAP technology 61 IMA# 61 POTELLIGENT ® 61 Alexza Staccato 61 Xencor XmAb 61 Glucagon Like Peptide 61 Successfully Completes Phase 61 ® lenalidomide 61 candidate NGX 61 Pyridorin TM 61 Nicotine Conjugate Vaccine 61 RenaZorb TM 61 drugs FUSILEV 61 sufentanil 61 ZANAFLEX CAPSULES ® tizanidine 61 HuCAL GOLD R 61 Inhalation Aerosol 61 aripiprazole Abilify 61 highly purified pasteurized 61 automated radiopharmaceutical distribution 61 XL# XL# 61 Metastatic Melanoma 61 t2cure GmbH 61 Quark Biotech 61 HuCNS SC ® 61 Submits Biologics License Application 61 Aurora Kinase 61 tetracycline antibiotic 61 selectively inhibited 61 Homspera ® 61 OTCBB NRGX 61 ALGRX 61 MET RET 61 midstage trials 61 diagnostic radiopharmaceutical 61 anti CTLA 61 diclofenac sodium 61 PRT# 61 Retisert R 61 anti infective treatments 61 Phase 2b Clinical Trial 61 antiangiogenesis therapies 61 acadesine 61 CD# monoclonal antibody 61 Tarceva TM 61 VBLOC vagal blocking 61 ISF# 61 Unigene nasal calcitonin 61 Gonal f ® 61 Thrombin 61 dasatinib Sprycel ® 61 TRACON Pharmaceuticals Inc. 61 JZP 61 oral taxane 61 Temsirolimus 61 drug conjugate 61 Inc. www.micromet inc.com 61 Granted Orphan Drug 61 Viprovex R 61 miRNA therapeutics 61 Zolpimist ™ 61 orally administered inhibitor 61 Kamada AAT 61 HQK 61 AeroLEF R 61 ELND-#/AZD-# 61 OvaRex ® MAb 61 Hycamtin ® 61 Pramlintide 61 Silodosin 61 Harbor BioSciences 61 Epratuzumab 61 XmAb ® 61 Taiho Pharmaceutical 61 buccal spray 61 Cellcept 61 tranilast 61 candidate epratuzumab 61 NYSE Amex PTN 61 EOquin TM phase 61 pulsatile delivery technology 61 Icatibant 61 CAPHOSOL R 61 telomerase inhibitor 61 Receives Orphan Drug 61 Oracea ® 61 interleukin IL -# 61 OMRIX Biopharmaceuticals Inc. 61 Drug Absorption 61 Calcitonin 61 diarrhea predominant irritable 61 Namenda XR 61 butyrylcholinesterase 61 BrachySil ™ 61 Traficet EN 61 ProEthic Pharmaceuticals 61 NexACT ® 61 AMPK activators 61 Present Preclinical Data 61 Elan NanoCrystal 61 Guanilib 61 HCD# [002] 61 Initiate Phase 61 AtuRNAi 61 Oncobionic 61 Antibody Drug Conjugate 61 opioid receptor antagonist 61 Xanthus Pharmaceuticals Inc. 61 novel antibody therapeutics 61 Prochymal TM 61 Polymer Microspheres 61 BioSilicon 61 Dabigatran etexilate 61 nilotinib Tasigna ® 61 Ridaforolimus 61 candidate AQ4N 61 Pentad TM 61 Randomized Phase 61 orally disintegrating 61 ChronVac C R 61 TURNING INSIGHTS INTO HOPE 61 Xelox 61 LHRH antagonists 61 OTCBB PYTO 61 Inc. OTCBB ALRX 61 pan histone deacetylase 61 DNA RNA Medicines 61 antigen fusion 61 drug GAP #B# 61 barrier gauze dressings 61 NS5b 61 ELADUR ™ 61 GIPET 61 ZADAXIN ® 61 triciribine phosphate monohydrate 61 Indomethacin 61 Galectin 61 Mylan Receives Approval 61 muscarinic receptor agonist 61 Presents Positive 61 See BioWorld Today 61 Nasdaq HALO 61 myelodysplastic myeloproliferative diseases 61 NEBIDO VANTAS SUPPRELIN LA 61 interferon beta 1a infertility 61 COLAZAL ® 61 LEVADEX ™ 61 Company TAIFUN R 61 MP4 molecule 61 zanolimumab 61 Allovectin 7 61 SMARTICLES ® 61 CIMZIA ™ 61 R bendamustine hydrochloride 61 intravesical instillation 61 CysDisplay R 61 using Innocoll proprietary 61 rALLy clinical trial 61 midstage clinical 61 Tumour Vascular Disrupting Agent 61 Nasdaq MNKD focused